Agile Therapeutics
Princeton, US · Delaware corporation · 8 employees on LinkedIn · 3 known investors
Find your way into Agile Therapeutics
377 people in our graph share verified history with the Agile Therapeutics team — schools, employers, funds. One of them is your warm intro.
Bruce Rothunlockedknows Katie MacFarlane · together at Parke-Davis (overlapped)
knows the team · via Sena Therapeutics
×3knows the team · via Ortho-McNeil Pharmaceutical
knows the team · via ObsEva SA
×2knows the team · via Ferring Pharmaceuticals
×2knows the team · via Drexel University
Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusion® transdermal technology platform. The company focuses on providing healthcare options for women through innovative delivery mechanisms.
Founders & leadership
KM
Katie MacFarlaneChief Commercial Officer2009–2016Katie MacFarlane is Executive Officer at Agile Therapeutics, which develops contraceptive and women's health products using transdermal technology. She has spent over 35 years in pharmaceutical roles including senior management positions at Hoffmann-LaRoche, Parke-Davis, Pfizer, and Warner Chilcott, with experience in marketing, sales, clinical research, and product launch strategy.
SM
Scott M. CoianteExecutive
AA
Al AltomariChairman & CEO2010–2024Al Altomari served as Chairman and CEO of Agile Therapeutics from 2010 until its merger with InSud Pharma, and previously led Barrier Therapeutics as CEO before its 2008 acquisition by GSK/Stiefel Laboratories. He spent over two decades at Johnson & Johnson in roles spanning finance, business development, and general management, including serving as General Manager of Ortho Neutrogena and heading the Women's Health Care Franchise.
EG
Elizabeth GarnerChief Medical Officer2014–2019Elizabeth Garner has over a decade of experience in women's health, including work in clinical development, regulatory strategy, and assessment of therapeutics and devices. She serves as Board Chair at NUA Surgical and Owner and President of KNI Health Consultants, LLC.
Board
AL
Abhijeet LeleBoard director
AN
LP
Lorenzo PellegriniBoard director
WT
William T. McKeeBoard director
JH
John HubbardBoard director
JT
James TursiBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$30.8M disclosed across 3 rounds · 2014–2019
▶$7.8MraisedMar 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$7.8MraisedMar 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Seth H.Z. FischerDirector
- William T. McKeeDirector
- James P. TursiDirector
- Abhijeet LeleDirector
- Scott M. CoianteExecutive Officer
- Al AltomariExecutive Officer, Director
- Elizabeth GarnerExecutive Officer
- Ajit S. ShettyDirector
- John HubbardDirector
- Robert G. ConwayExecutive Officer
- Geoffrey P. GilmoreExecutive Officer
- Offering amount
- $7.8M
- Amount sold
- $7.8M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedFeb 2015 · 8 investors · PharmaceuticalsRule 506(b)
▶$20MraisedFeb 2015 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Katie MacFarlaneExecutive Officer
- Karen HongDirector
- William T. McKeeDirector
- John HubbardDirector
- Scott M. CoianteExecutive Officer
- Al AltomariExecutive Officer, Director
- Abhijeet LeleDirector
- Elizabeth GarnerExecutive Officer
- Andrew N. SchiffDirector
- James TursiDirector
- Offering amount
- $20M
- Amount sold
- $20M
- Sales commissions
- $600K
- Placement agents
- William Blair & Company, L.L.C.
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedMay 2014 · 9 investors · PharmaceuticalsRule 506(b)
▶$3MraisedMay 2014 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Katie MacFarlaneExecutive Officer
- Elizabeth GarnerExecutive Officer
- Karen HongDirector
- Al AltomariExecutive Officer, Director
- Scott M. CoianteExecutive Officer
- Andrew N. SchiffDirector
- Abhijeet LeleDirector
- William T. McKeeDirector
- Lorenzo PellegriniDirector
- Offering amount
- $3M
- Amount sold
- $3M
- Proceeds to insiders
- $300K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Pandia Health15 shared keywordsPandia Health is a doctor-founded, women-led telehealth service that provides online consultations with board-certified physicians specializing in hormonal and reproductive care, along with free home delivery of prescriptions. It offers personalized hormone therapy for needs such as birth control, hormonal balance, menopause, and sexual wellness, using medication-matching technology and patient data.
PlushCare14 shared keywordsPlushCare is a telehealth service that connects patients with board-certified primary care doctors and therapists through an app for virtual appointments, prescriptions, and ongoing care. It covers weight management, urgent care, pediatric care, chronic disease treatment, online therapy, and prescription discounts, serving patients across all 50 U.S. states.
Walgreens13 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Medscape12 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies competing with Agile Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Agile Therapeutics do?
- Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusion® transdermal technology platform. The company focuses on providing healthcare options for women through innovative delivery mechanisms.
- Who are Agile Therapeutics's investors?
- Agile Therapeutics's investors include Aisling Capital, Kaiser Permanente Ventures, De Novo Ventures.
- How much funding has Agile Therapeutics raised?
- Agile Therapeutics has disclosed $30.8M raised across 3 rounds.
- Where is Agile Therapeutics headquartered?
- Agile Therapeutics is headquartered in Princeton, US.